对波斯特马等人的评论。比利时≥60岁成年人接种呼吸道合胞病毒疫苗不同保护期的预测公共卫生和经济影响。2023年，，990。
Comment on Postma et al. Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium. 2023, , 990.
作者信息
Standaert Baudouin
机构信息
Department Care and Ethics, Faculty of Medicine and Life Sciences, University Hasselt, 3590 Diepenbeek, Belgium.
HEBO bv, 2020 Antwerpen, Belgium.
出版信息
Vaccines (Basel). 2023 Oct 27;11(11):1646. doi: 10.3390/vaccines11111646.
Abstract
Presently, there are at least five important vaccine producers that have already launched or intend to launch a new vaccine designed to prevent infections caused by the Respiratory Syncytial Virus (RSV), which is highly prevalent in the youngest as well as the oldest age groups [...].
摘要
目前，至少有五家重要的疫苗生产商已经推出或打算推出一种旨在预防呼吸道合胞病毒（RSV）感染的新型疫苗，RSV在最年幼和最年长的年龄组中高度流行[……]。
Zotero 插件